Click here to view the programme of Session 3a

Update on biomarker in gastric cancer
Chairs :
Heike Grabsch (pathologist, Maastricht UMC, The Netherlands) and
Ryoji Kushima, Shiga University of Medical Science, Seta, Otsu, Shiga, Japan
10.45 Biomarkers in routine H&E stained sections
Luca Saragoni, pathologist, Universita di Bologna, Italy
11:05 Molecular biomarkers
Patrick Tan, Translational scientist, Duke-NUS Medical School, Singapore
11:25 Circulating DNA
Nicole van Grieken, pathologist, Amsterdam UMC, The Netherlands
11:45 Accepted oral abstract 02.2.4: Host Tissue Factors Predict Immune Surveillance and Clinical Outcomes in Gastric Cancer
Emily Stroobant, Resident, Memorial Sloan Kettering Cancer Center, United States
11:55 Accepted oral abstract 02.2.5: Unraveling the Role of FGFBP2+NK Cells as Predictive Biomarkers in Gastric Adenocarcinoma Immunotherapy
Hongda Pan, Surgeon, Fudan University Shanghai Cancer Center, China
12:05 Accepted oral abstract 02.2.6: B cells in gastric cancer: spatially resolved profiles and associations with chemotherapy response
Joseph Zhao, Resident, National University Cancer Institute, Singapore
12:15 End of session
- Parallel session 1
Session 3a: Pathology / Translational research
Date: 09 May 2025Time: 10:45 - 12:15 CET